Comparison of Individualized Sodium Management Versus Standard Treatment in Hemodialysis

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 130 participants.

Also called NCT06341452

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 130 participants (planned count) (from the registry)
Sponsor
Fresenius Medical Care Deutschland GmbH (from the registry)
Registry
  • NCT NCT06341452
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Czechia (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06341452. Randomized; no masking; primary purpose treatment. Start 2025-12-16 (actual); primary completion 2026-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of Individualized Sodium Management Versus Standard Treatment in Hemodialysis
Acronym
SODIAH
Condition
End Stage Renal Disease
Intervention (Device)
Hemodialysis or Hemodiafiltration either with sodium zero-diffusive treatment or standard treatment without sodium-control
Lead sponsor
Fresenius Medical Care Deutschland GmbH (class: industry)

Record details

Record id
cardio:ct-nct06341452
Content hash
72c6bb0207beaaa5d48fd677011d053da84cdaf445ca62e10421a6238d37c4c5